Jove R - Search Results

1

Prostate adenocarcinoma: cellular and molecular abnormalities.

Mora LB, Buettner R, Ahmad N, Bassel Y, Jove R, Seigne JD. Mora LB, et al. Among authors: jove r. Cancer Control. 2001 Nov-Dec;8(6):551-61. doi: 10.1177/107327480100800612. Cancer Control. 2001. PMID: 11807425 Free article. Review. No abstract available.

2

Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Mora LB, et al. Among authors: jove r. Cancer Res. 2002 Nov 15;62(22):6659-66. Cancer Res. 2002. PMID: 12438264

3

Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.

Nam S, Kim D, Cheng JQ, Zhang S, Lee JH, Buettner R, Mirosevich J, Lee FY, Jove R. Nam S, et al. Among authors: jove r. Cancer Res. 2005 Oct 15;65(20):9185-9. doi: 10.1158/0008-5472.CAN-05-1731. Cancer Res. 2005. PMID: 16230377

4

Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10.

Torres-Roca JF, DeSilvio M, Mora LB, Khor LY, Hammond E, Ahmad N, Jove R, Forman J, Lee RJ, Sandler H, Pollack A. Torres-Roca JF, et al. Among authors: jove r. Urology. 2007 Mar;69(3):505-9. doi: 10.1016/j.urology.2006.11.006. Urology. 2007. PMID: 17382154 Clinical Trial.

5

Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.

Buettner R, Mora LB, Jove R. Buettner R, et al. Among authors: jove r. Clin Cancer Res. 2002 Apr;8(4):945-54. Clin Cancer Res. 2002. PMID: 11948098 Review.

6

Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling.

Schroeder A, Herrmann A, Cherryholmes G, Kowolik C, Buettner R, Pal S, Yu H, Müller-Newen G, Jove R. Schroeder A, et al. Among authors: jove r. Cancer Res. 2014 Feb 15;74(4):1227-37. doi: 10.1158/0008-5472.CAN-13-0594. Epub 2013 Oct 31. Cancer Res. 2014. PMID: 24177177 Free PMC article.

7

Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity.

Turkson J, Zhang S, Palmer J, Kay H, Stanko J, Mora LB, Sebti S, Yu H, Jove R. Turkson J, et al. Among authors: jove r. Mol Cancer Ther. 2004 Dec;3(12):1533-42. Mol Cancer Ther. 2004. PMID: 15634646

8

Stat3 regulates genes common to both wound healing and cancer.

Dauer DJ, Ferraro B, Song L, Yu B, Mora L, Buettner R, Enkemann S, Jove R, Haura EB. Dauer DJ, et al. Among authors: jove r. Oncogene. 2005 May 12;24(21):3397-408. doi: 10.1038/sj.onc.1208469. Oncogene. 2005. PMID: 15735721

9

A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells.

Turkson J, Zhang S, Mora LB, Burns A, Sebti S, Jove R. Turkson J, et al. Among authors: jove r. J Biol Chem. 2005 Sep 23;280(38):32979-88. doi: 10.1074/jbc.M502694200. Epub 2005 Jul 26. J Biol Chem. 2005. PMID: 16046414 Free article.

10

Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent alone.

Burdelya L, Catlett-Falcone R, Levitzki A, Cheng F, Mora LB, Sotomayor E, Coppola D, Sun J, Sebti S, Dalton WS, Jove R, Yu H. Burdelya L, et al. Among authors: jove r. Mol Cancer Ther. 2002 Sep;1(11):893-9. Mol Cancer Ther. 2002. PMID: 12481410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters